MOR - MorphoSys AG Net Margin

MorphoSys Corp - graphic logo of issuer MOR

MorphoSys AG (MOR) minimizes risks by developing targeted antibodies in partnership with pharmaceutical behemoths. Average sales margins show a pivot driven by strict FDA oversight and exclusive patents for oncology drugs. Stable demand for innovation renders the asset defensive, isolating it from macroeconomic volatility. The value of -226.90 is established as the baseline value determining the company's current operational efficiency.

morphosys.com (MOR) Company Sales Margin: for the period 07/04/2022 - 08/10/2024

Summary analytical data breakdowns for MorphoSys AG (MOR)

- share price and expert price forecast:
Summary company analytics:morphosys.com - MOR
Manufactured product of MorphoSys Corporation

This indicator calculates the ratio of net income to revenue, determining the efficiency of cost management. It demonstrates the portion of income remaining after all operating and tax payments. For MorphoSys AG (MOR), this metric stabilizes due to royalties and the diversification of its antibody portfolio. Analyzing the net profit margin allows for the identification of abnormal peaks, which helps investors avoid overpaying for the asset.

Competitor analysis

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|American Oncology Network (AONC) - Net Margin|BeiGene - Net Sales Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Sales by Net Profit|ELEV (Elevation Oncology, Inc.) - Return on Sales by Net Profit|iCAD Inc. - Net Profit Rate|Return on Sales by Net Profit IKNA|Net Sales Margin notablelabs.com|Return on Sales by Net Profit VIRX (Viracta Therapeutics Inc.)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)